<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The human cysteine dioxygenase 1 (CDO1) gene is a non-<z:chebi fb="4" ids="30413">heme</z:chebi> structured, iron-containing metalloenzyme involved in the conversion of cysteine to cysteine <z:chebi fb="0" ids="9341">sulfinate</z:chebi>, and plays a key role in <z:chebi fb="5" ids="15891">taurine</z:chebi> biosynthesis </plain></SENT>
<SENT sid="1" pm="."><plain>In our search for novel methylated gene promoters, we have analyzed differential <z:chebi fb="40" ids="33697">RNA</z:chebi> expression profiles of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) cell lines with or without treatment of <z:chebi fb="0" ids="50131">5-aza-2'-deoxycytidine</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Among the genes identified, the CDO1 promoter was found to be differentially methylated in primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues with high frequency compared to <z:mpath ids='MPATH_458'>normal</z:mpath> colon tissues </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, a statistically significant difference in the frequency of CDO1 promoter methylation was observed between primary <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissues derived from breast, esophagus, lung, bladder and stomach </plain></SENT>
<SENT sid="4" pm="."><plain>Downregulation of CDO1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein levels were observed in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell lines and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> derived from these tissue types </plain></SENT>
<SENT sid="5" pm="."><plain>Expression of CDO1 was tightly controlled by promoter methylation, suggesting that promoter methylation and silencing of CDO1 may be a common event in human <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, forced expression of full-length CDO1 in human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells markedly decreased the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell growth in an in vitro cell culture and/or an in vivo mouse model, whereas knockdown of CDO1 increased cell growth in culture </plain></SENT>
<SENT sid="7" pm="."><plain>Our data implicate CDO1 as a novel <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene and a potentially valuable molecular marker for human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
</text></document>